Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
alcea digitata + malva sylvestris
- Development stage
- Phase 2
- Lead developer
- Shiraz University of Medical Sciences
- Administration
- Oral, Topical
01
Overview
A traditional Persian herbal combination consisting of the flower powders of Alcea digitata (also known as Althaea digitata) and Malva sylvestris. This preparation is primarily investigated by Iranian medical institutions for its mucosal protective, anti-inflammatory, and antioxidant properties. It is used to mitigate radiation-induced complications in cancer patients, such as xerostomia in head and neck cancer and proctitis in prostate cancer. The therapeutic effect is attributed to its high content of mucilage, polysaccharides, and flavonoids, which provide a physical barrier and reduce oxidative stress in irradiated tissues.
- Other names
- Althaea digitata + Malva sylvestrisKhatmi + Khobazifinger mallow + common mallow
Beyond the preview
Go deeper on alcea digitata + malva sylvestris.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on alcea digitata + malva sylvestris.